Tonix Pharmaceuticals Holding (TNXP) Cash from Operations (2010 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Cash from Operations of 42318000.0 for Q1 2026, down 155.25% year-over-year from 76592808.08 in Q1 2025, and down 6.73% quarter-over-quarter from 39650000.0 in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Cash from Operations (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Cash from Operations history runs 17 years deep, the most recent figure standing at 42318000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 155.25% year-over-year to 42318000.0; the TTM figure through Mar 2026 stood at 125583000.0 (down 109.55% YoY), while the FY2025 annual figure was 99844000.0, down 63.88% from the prior year.
- Cash from Operations for Q1 2026 stood at 42318000.0, down from 39650000.0 in the prior quarter.
- The five-year high for Cash from Operations was 9919000.0 in Q2 2024, with the low at 42318000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 22340000.0 (2023), against an average of 23714294.12.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations surged 57.55% in 2024, then slumped 171.02% in 2025.
- Tonix Pharmaceuticals Holding's Cash from Operations stood at 22301000.0 in 2022, then decreased by 0.17% to 22340000.0 in 2023, then soared by 34.51% to 14630000.0 in 2024, then plunged by 171.02% to 39650000.0 in 2025, then declined by 6.73% to 42318000.0 in 2026.
- Business Quant data shows TNXP's Cash from Operations at 42318000.0 in Q1 2026, 39650000.0 in Q4 2025, and 28782000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | -42.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -42.24 Mn |
| Jun 30, 2026 | -42.24 Mn |
| Mar 31, 2026 | -42.32 Mn |
| Mar 31, 2026 | -42.32 Mn |
| Dec 31, 2025 | -39.65 Mn |
| Dec 31, 2025 | -39.65 Mn |
| Sep 30, 2025 | -28.78 Mn |
| Sep 30, 2025 | -28.78 Mn |
| Jun 30, 2025 | -14.83 Mn |
| Jun 30, 2025 | -14.83 Mn |
| Mar 31, 2025 | -16.58 Mn |
| Mar 31, 2025 | -16.58 Mn |
| Dec 31, 2024 | -14.63 Mn |
| Dec 31, 2024 | -14.63 Mn |
| Sep 30, 2024 | -18.80 Mn |
| Sep 30, 2024 | -18.80 Mn |
| Jun 30, 2024 | -9.92 Mn |
| Jun 30, 2024 | -9.92 Mn |
| Mar 31, 2024 | -17.58 Mn |
| Mar 31, 2024 | -17.58 Mn |